These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9570380)
1. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma. Wu MS; Wang HP; Lin CC; Sheu JC; Shun CT; Lee WJ; Lin JT Cancer Lett; 1997 Nov; 120(1):9-14. PubMed ID: 9570380 [TBL] [Abstract][Full Text] [Related]
2. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220 [TBL] [Abstract][Full Text] [Related]
3. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors. Kim HT; Choi BH; Niikawa N; Lee TS; Chang SI Am J Med Genet; 1998 Dec; 80(4):391-5. PubMed ID: 9856569 [TBL] [Abstract][Full Text] [Related]
4. Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues. Micha AE; Hähnel S; Friess H; Büchler MW; Adler G; Gress TM Digestion; 1999; 60(5):477-83. PubMed ID: 10473973 [TBL] [Abstract][Full Text] [Related]
5. Genomic imprinting of IGF2 and H19 in human meningiomas. Müller S; Zirkel D; Westphal M; Zumkeller W Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131 [TBL] [Abstract][Full Text] [Related]
6. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor. Yballe CM; Vu TH; Hoffman AR J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375 [TBL] [Abstract][Full Text] [Related]
7. Loss of imprinting of igf2 in renal-cell carcinomas. Oda H; Kume H; Shimizu Y; Inoue T; Ishikawa T Int J Cancer; 1998 Jan; 75(3):343-6. PubMed ID: 9455791 [TBL] [Abstract][Full Text] [Related]
8. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Kim KS; Lee YI Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364 [TBL] [Abstract][Full Text] [Related]
9. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489 [TBL] [Abstract][Full Text] [Related]
10. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma. Casola S; Pedone PV; Cavazzana AO; Basso G; Luksch R; d'Amore ES; Carli M; Bruni CB; Riccio A Oncogene; 1997 Mar; 14(12):1503-10. PubMed ID: 9136994 [TBL] [Abstract][Full Text] [Related]
11. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II. Kim SJ; Park SE; Lee C; Lee SY; Jo JH; Kim JM; Oh YK Biochim Biophys Acta; 2002 Apr; 1586(3):307-15. PubMed ID: 11997082 [TBL] [Abstract][Full Text] [Related]
12. IGF2 but not H19 shows loss of imprinting in human glioma. Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084 [TBL] [Abstract][Full Text] [Related]
13. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting. Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881 [TBL] [Abstract][Full Text] [Related]
14. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors. Ross JA; Schmidt PT; Perentesis JP; Davies SM Cancer; 1999 Mar; 85(6):1389-94. PubMed ID: 10189147 [TBL] [Abstract][Full Text] [Related]
15. Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas. Rainho CA; Kowalski LP; Rogatto SR Head Neck; 2001 Oct; 23(10):851-9. PubMed ID: 11592232 [TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach. Stier S; Neuhaus T; Albers P; Wernert N; Grünewald E; Forkert R; Vetter H; Ko Y Arch Toxicol; 2006 Oct; 80(10):713-8. PubMed ID: 16721595 [TBL] [Abstract][Full Text] [Related]
17. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer. Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526 [TBL] [Abstract][Full Text] [Related]
18. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642 [TBL] [Abstract][Full Text] [Related]
19. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases. Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595 [TBL] [Abstract][Full Text] [Related]
20. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. Nonomura N; Miki T; Nishimura K; Kanno N; Kojima Y; Okuyama A J Urol; 1997 May; 157(5):1977-9. PubMed ID: 9112575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]